UFP Technologies, Inc. (UFPT)
USD 187.03
(-3.41%)
USD 187.03
(-3.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 404.13 Million USD | 7.04% |
| 2022 | 377.54 Million USD | 12.99% |
| 2021 | 334.13 Million USD | 64.43% |
| 2020 | 203.2 Million USD | 7.65% |
| 2019 | 188.75 Million USD | -0.44% |
| 2018 | 189.59 Million USD | 37.18% |
| 2017 | 138.2 Million USD | 8.03% |
| 2016 | 127.93 Million USD | 6.66% |
| 2015 | 119.95 Million USD | 5.51% |
| 2014 | 113.69 Million USD | 8.26% |
| 2013 | 105.02 Million USD | 6.49% |
| 2012 | 98.61 Million USD | 23.7% |
| 2011 | 79.72 Million USD | 11.02% |
| 2010 | 71.8 Million USD | 20.78% |
| 2009 | 59.45 Million USD | 22.02% |
| 2008 | 48.72 Million USD | 6.96% |
| 2007 | 45.55 Million USD | 16.69% |
| 2006 | 39.03 Million USD | -11.28% |
| 2005 | 44 Million USD | 11.02% |
| 2004 | 39.63 Million USD | 7.85% |
| 2003 | 36.74 Million USD | 3.86% |
| 2002 | 35.38 Million USD | -7.14% |
| 2001 | 38.1 Million USD | -5.58% |
| 2000 | 40.35 Million USD | 26.5% |
| 1999 | 31.9 Million USD | 6.69% |
| 1998 | 29.9 Million USD | 18.65% |
| 1997 | 25.2 Million USD | 10.04% |
| 1996 | 22.9 Million USD | 10.1% |
| 1995 | 20.8 Million USD | 8.9% |
| 1994 | 19.1 Million USD | -5.45% |
| 1993 | 20.2 Million USD | 77.19% |
| 1992 | 11.4 Million USD | 10.68% |
| 1991 | 10.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 422.39 Million USD | 3.61% |
| 2024 Q3 | 638.5 Million USD | 51.16% |
| 2024 Q1 | 407.67 Million USD | 0.88% |
| 2023 Q3 | 399.81 Million USD | 0.46% |
| 2023 Q2 | 397.99 Million USD | 1.85% |
| 2023 Q1 | 390.78 Million USD | 3.51% |
| 2023 FY | 404.13 Million USD | 7.04% |
| 2023 Q4 | 404.13 Million USD | 1.08% |
| 2022 FY | 377.54 Million USD | 12.99% |
| 2022 Q4 | 377.54 Million USD | -3.67% |
| 2022 Q3 | 391.91 Million USD | -0.79% |
| 2022 Q2 | 395.05 Million USD | 8.73% |
| 2022 Q1 | 363.34 Million USD | 8.74% |
| 2021 Q3 | 220.68 Million USD | 1.56% |
| 2021 Q4 | 334.13 Million USD | 51.41% |
| 2021 FY | 334.13 Million USD | 64.43% |
| 2021 Q2 | 217.28 Million USD | 3.88% |
| 2021 Q1 | 209.18 Million USD | 2.94% |
| 2020 Q3 | 200.66 Million USD | 1.75% |
| 2020 FY | 203.2 Million USD | 7.65% |
| 2020 Q4 | 203.2 Million USD | 1.27% |
| 2020 Q1 | 194.21 Million USD | 2.89% |
| 2020 Q2 | 197.21 Million USD | 1.55% |
| 2019 Q4 | 188.75 Million USD | -5.78% |
| 2019 Q3 | 200.33 Million USD | 2.76% |
| 2019 Q2 | 194.96 Million USD | 1.19% |
| 2019 Q1 | 192.66 Million USD | 1.62% |
| 2019 FY | 188.75 Million USD | -0.44% |
| 2018 Q3 | 193.76 Million USD | 0.22% |
| 2018 Q1 | 194.22 Million USD | 40.53% |
| 2018 Q2 | 193.34 Million USD | -0.45% |
| 2018 Q4 | 189.59 Million USD | -2.15% |
| 2018 FY | 189.59 Million USD | 37.18% |
| 2017 FY | 138.2 Million USD | 8.03% |
| 2017 Q1 | 131.51 Million USD | 2.8% |
| 2017 Q3 | 137.09 Million USD | 2.54% |
| 2017 Q2 | 133.69 Million USD | 1.65% |
| 2017 Q4 | 138.2 Million USD | 0.81% |
| 2016 Q2 | 124.97 Million USD | 5.06% |
| 2016 Q4 | 127.93 Million USD | -0.09% |
| 2016 Q3 | 128.04 Million USD | 2.45% |
| 2016 Q1 | 118.96 Million USD | -0.82% |
| 2016 FY | 127.93 Million USD | 6.66% |
| 2015 Q4 | 119.95 Million USD | -0.24% |
| 2015 Q2 | 118.26 Million USD | 3.71% |
| 2015 FY | 119.95 Million USD | 5.51% |
| 2015 Q3 | 120.23 Million USD | 1.67% |
| 2015 Q1 | 114.02 Million USD | 0.3% |
| 2014 Q1 | 105.69 Million USD | 0.64% |
| 2014 FY | 113.69 Million USD | 8.26% |
| 2014 Q4 | 113.69 Million USD | 1.38% |
| 2014 Q3 | 112.13 Million USD | 2.99% |
| 2014 Q2 | 108.88 Million USD | 3.02% |
| 2013 Q3 | 104.34 Million USD | 2.37% |
| 2013 Q2 | 101.92 Million USD | 2.88% |
| 2013 Q1 | 99.06 Million USD | 0.46% |
| 2013 Q4 | 105.02 Million USD | 0.65% |
| 2013 FY | 105.02 Million USD | 6.49% |
| 2012 Q3 | 87.52 Million USD | 4.37% |
| 2012 FY | 98.61 Million USD | 23.7% |
| 2012 Q1 | 80.34 Million USD | 0.78% |
| 2012 Q2 | 83.86 Million USD | 4.38% |
| 2012 Q4 | 98.61 Million USD | 12.67% |
| 2011 FY | 79.72 Million USD | 11.02% |
| 2011 Q1 | 73.87 Million USD | 2.87% |
| 2011 Q4 | 79.72 Million USD | 1.11% |
| 2011 Q3 | 78.84 Million USD | 2.94% |
| 2011 Q2 | 76.59 Million USD | 3.69% |
| 2010 Q1 | 60.41 Million USD | 1.63% |
| 2010 FY | 71.8 Million USD | 20.78% |
| 2010 Q3 | 66.75 Million USD | 4.74% |
| 2010 Q4 | 71.8 Million USD | 7.57% |
| 2010 Q2 | 63.73 Million USD | 5.48% |
| 2009 Q4 | 59.45 Million USD | 4.68% |
| 2009 Q2 | 50.9 Million USD | 2.62% |
| 2009 Q1 | 49.6 Million USD | 1.82% |
| 2009 FY | 59.45 Million USD | 22.02% |
| 2009 Q3 | 56.79 Million USD | 11.56% |
| 2008 Q1 | 47.9 Million USD | 5.16% |
| 2008 FY | 48.72 Million USD | 6.96% |
| 2008 Q4 | 48.72 Million USD | -3.29% |
| 2008 Q3 | 50.38 Million USD | 2.12% |
| 2008 Q2 | 49.33 Million USD | 3.0% |
| 2007 Q3 | 43.01 Million USD | 5.93% |
| 2007 Q4 | 45.55 Million USD | 5.9% |
| 2007 Q1 | 39.23 Million USD | 0.51% |
| 2007 FY | 45.55 Million USD | 16.69% |
| 2007 Q2 | 40.6 Million USD | 3.5% |
| 2006 Q1 | 42.1 Million USD | -4.3% |
| 2006 Q3 | 39.77 Million USD | -4.83% |
| 2006 Q4 | 39.03 Million USD | -1.86% |
| 2006 FY | 39.03 Million USD | -11.28% |
| 2006 Q2 | 41.79 Million USD | -0.75% |
| 2005 Q1 | 40.1 Million USD | 1.19% |
| 2005 Q4 | 44 Million USD | 4.34% |
| 2005 Q2 | 41.62 Million USD | 3.8% |
| 2005 FY | 44 Million USD | 11.02% |
| 2005 Q3 | 42.16 Million USD | 1.3% |
| 2004 Q2 | 37.66 Million USD | 1.5% |
| 2004 Q4 | 39.63 Million USD | 3.45% |
| 2004 FY | 39.63 Million USD | 7.85% |
| 2004 Q1 | 37.11 Million USD | 0.99% |
| 2004 Q3 | 38.31 Million USD | 1.7% |
| 2003 Q4 | 36.74 Million USD | -0.98% |
| 2003 FY | 36.74 Million USD | 3.86% |
| 2003 Q1 | 35.75 Million USD | 1.05% |
| 2003 Q3 | 37.11 Million USD | 1.8% |
| 2003 Q2 | 36.45 Million USD | 1.96% |
| 2002 Q3 | 36.13 Million USD | -6.53% |
| 2002 Q4 | 35.38 Million USD | -2.09% |
| 2002 Q2 | 38.66 Million USD | -2.64% |
| 2002 Q1 | 39.71 Million USD | 4.23% |
| 2002 FY | 35.38 Million USD | -7.14% |
| 2001 FY | 38.1 Million USD | -5.58% |
| 2001 Q1 | 40.86 Million USD | 1.27% |
| 2001 Q2 | 39.54 Million USD | -3.24% |
| 2001 Q3 | 39.22 Million USD | -0.8% |
| 2001 Q4 | 38.1 Million USD | -2.86% |
| 2000 FY | 40.35 Million USD | 26.5% |
| 2000 Q1 | 43.06 Million USD | 34.99% |
| 2000 Q2 | 43.34 Million USD | 0.65% |
| 2000 Q3 | 42.22 Million USD | -2.56% |
| 2000 Q4 | 40.35 Million USD | -4.44% |
| 1999 Q2 | 31.9 Million USD | 2.9% |
| 1999 Q4 | 31.9 Million USD | -0.93% |
| 1999 Q3 | 32.2 Million USD | 0.94% |
| 1999 FY | 31.9 Million USD | 6.69% |
| 1999 Q1 | 31 Million USD | 3.68% |
| 1998 Q1 | 25.5 Million USD | 1.19% |
| 1998 Q4 | 29.9 Million USD | 14.56% |
| 1998 FY | 29.9 Million USD | 18.65% |
| 1998 Q3 | 26.1 Million USD | 1.16% |
| 1998 Q2 | 25.8 Million USD | 1.18% |
| 1997 Q2 | 25.3 Million USD | -0.78% |
| 1997 Q1 | 25.5 Million USD | 11.35% |
| 1997 Q3 | 25.7 Million USD | 1.58% |
| 1997 Q4 | 25.2 Million USD | -1.95% |
| 1997 FY | 25.2 Million USD | 10.04% |
| 1996 Q3 | 22.5 Million USD | 3.21% |
| 1996 FY | 22.9 Million USD | 10.1% |
| 1996 Q4 | 22.9 Million USD | 1.78% |
| 1996 Q2 | 21.8 Million USD | 0.46% |
| 1996 Q1 | 21.7 Million USD | 4.33% |
| 1995 FY | 20.8 Million USD | 8.9% |
| 1995 Q1 | 19.4 Million USD | 1.57% |
| 1995 Q3 | 20 Million USD | 5.26% |
| 1995 Q2 | 19 Million USD | -2.06% |
| 1995 Q4 | 20.8 Million USD | 4.0% |
| 1994 Q1 | 19.8 Million USD | -1.98% |
| 1994 FY | 19.1 Million USD | -5.45% |
| 1994 Q3 | 19.9 Million USD | -1.97% |
| 1994 Q4 | 19.1 Million USD | -4.02% |
| 1994 Q2 | 20.3 Million USD | 2.53% |
| 1993 Q4 | 20.2 Million USD | 0.0% |
| 1993 FY | 20.2 Million USD | 77.19% |
| 1992 Q4 | 11.4 Million USD | 0.0% |
| 1992 FY | 11.4 Million USD | 10.68% |
| 1991 Q4 | 10.3 Million USD | 0.0% |
| 1991 FY | 10.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -1188.452% |
| BrainsWay Ltd. | 62.97 Million USD | -541.771% |
| Cerus Corporation | 197.74 Million USD | -104.369% |
| Envoy Medical, Inc. | 7.64 Million USD | -5189.738% |
| electroCore, Inc. | 16.38 Million USD | -2366.199% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -5153.978% |
| IceCure Medical Ltd | 16.41 Million USD | -2362.742% |
| Inogen, Inc. | 326.19 Million USD | -23.894% |
| OrthoPediatrics Corp. | 449.58 Million USD | 10.109% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -1381.98% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -2337.637% |
| MaxCyte, Inc. | 268.27 Million USD | -50.643% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -4890.988% |
| Nexalin Technology, Inc. | 3.63 Million USD | -11027.35% |
| Orthofix Medical Inc. | 925.31 Million USD | 56.324% |
| PAVmed Inc | 33.11 Million USD | -1120.254% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -181.722% |
| RxSight, Inc. | 182.55 Million USD | -121.384% |
| Sight Sciences, Inc. | 166.65 Million USD | -142.504% |
| SI-BONE, Inc. | 230.42 Million USD | -75.387% |
| TELA Bio, Inc. | 78.04 Million USD | -417.804% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -60.431% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -3666.412% |
| Acutus Medical, Inc. | 53.96 Million USD | -648.955% |
| Talis Biomedical Corporation | 98.34 Million USD | -310.958% |
| Spectral AI, Inc. | 10.69 Million USD | -3679.798% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -84.834% |
| CVRx, Inc. | 115.22 Million USD | -250.724% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -588.935% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -12872.815% |
| Bioventus Inc. | 810.91 Million USD | 50.163% |
| Venus Concept Inc. | 93.65 Million USD | -331.52% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -1470.985% |
| LivaNova PLC | 2.42 Billion USD | 83.366% |
| 908 Devices Inc. | 202.98 Million USD | -99.1% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 49.81% |
| Nemaura Medical Inc. | 14.56 Million USD | -2675.043% |
| NeuroPace, Inc. | 107.65 Million USD | -275.413% |
| LENSAR, Inc. | 69.58 Million USD | -480.78% |
| Apyx Medical Corporation | 79.24 Million USD | -410.015% |
| Cutera, Inc. | 346.29 Million USD | -16.704% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -861.862% |
| BioSig Technologies, Inc. | 1.79 Million USD | -22376.974% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -49.33% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -847.32% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 89.314% |
| Axonics, Inc. | 719.92 Million USD | 43.864% |
| Outset Medical, Inc. | 313.8 Million USD | -28.787% |
| IRIDEX Corporation | 34.43 Million USD | -1073.586% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 0.144% |
| IRadimed Corporation | 92.15 Million USD | -338.534% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -7591.968% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1834.796% |
| Telesis Bio, Inc. | 70.41 Million USD | -473.967% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -162.251% |
| Varex Imaging Corporation | 1.24 Billion USD | 67.659% |
| Quipt Home Medical Corp. | 247.4 Million USD | -63.348% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4240.881% |
| Pulmonx Corporation | 178.95 Million USD | -125.836% |
| Dynatronics Corporation | 25.94 Million USD | -1457.931% |
| Modular Medical, Inc. | 13.8 Million USD | -2827.037% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -3667.465% |
| Semler Scientific, Inc. | 78.06 Million USD | -417.692% |
| InMode Ltd. | 863.28 Million USD | 53.186% |
| Bruker Corporation | 4.24 Billion USD | 90.491% |
| Cytosorbents Corporation | 53.26 Million USD | -658.789% |
| DexCom, Inc. | 6.26 Billion USD | 93.549% |
| Align Technology, Inc. | 6.08 Billion USD | 93.357% |
| Viveve Medical, Inc. | 25.91 Million USD | -1459.588% |
| ZimVie Inc. | 1.2 Billion USD | 66.471% |
| Movano Inc. | 9.42 Million USD | -4189.736% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 18.794% |
| Nexalin Technology, Inc. | 3.63 Million USD | -11027.35% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -588.935% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 57.578% |
| Profound Medical Corp. | 43.68 Million USD | -825.086% |
| Insulet Corporation | 2.58 Billion USD | 84.385% |
| enVVeno Medical Corporation | 48.63 Million USD | -730.957% |
| Surmodics, Inc. | 185.73 Million USD | -117.59% |
| iCAD, Inc. | 41.41 Million USD | -875.75% |
| Nuwellis, Inc. | 9.77 Million USD | -4036.499% |
| Biotricity, Inc. | 5.94 Million USD | -6700.631% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 6.697% |
| Aethlon Medical, Inc. | 8.24 Million USD | -4801.005% |
| InspireMD, Inc. | 47.64 Million USD | -748.259% |
| PAVmed Inc. | 33.11 Million USD | -1120.254% |
| BIOLASE, Inc. | 35.1 Million USD | -1051.352% |
| Beyond Air, Inc. | 56.96 Million USD | -609.496% |
| FONAR Corporation | 214.24 Million USD | -88.632% |
| AxoGen, Inc. | 196.82 Million USD | -105.325% |
| Vivani Medical, Inc. | 45.79 Million USD | -782.451% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -43.597% |
| Inari Medical, Inc. | 674.23 Million USD | 40.06% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -1627.183% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -4152.67% |
| Tenon Medical, Inc. | 6.34 Million USD | -6269.362% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -4196.12% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -289.913% |
| AdaptHealth Corp. | 4.61 Billion USD | 91.252% |
| Sintx Technologies, Inc. | 15.36 Million USD | -2530.238% |
| NanoVibronix, Inc. | 6.67 Million USD | -5955.379% |
| Quanterix Corporation | 425.01 Million USD | 4.912% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4240.881% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -652.203% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 76.854% |
| TransMedics Group, Inc. | 706.04 Million USD | 42.761% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -539.537% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1786.332% |
| Hyperfine, Inc. | 94.19 Million USD | -329.024% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -50.437% |
| Biomerica, Inc. | 9.25 Million USD | -4267.149% |
| Bone Biologics Corporation | 3.73 Million USD | -10712.243% |
| AVITA Medical, Inc. | 144.33 Million USD | -179.989% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -8200.984% |
| Silk Road Medical, Inc | 265.3 Million USD | -52.327% |